Hemostemix Inc is making waves on the TSX Venture Exchange with a notable surge in its stock price.
Hemostemix Inc (HEM.V) is rising today, gaining 7.69% to reach a real-time close of CA$0.07. This uptick comes as the company takes strategic steps to engage investors and boost its operational capabilities.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeAdvertisement
Market cap
$13.32M
52W high
$0.14
52W low
$0.04
1W change
+8.33%
Beta
0.61
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
137.6%
Annualized
90-Day Vol
116.1%
Annualized
Trend (90d)
-31.1%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 – C$0.10 |
| 60 trading days | C$0.06 | C$0.03 – C$0.12 |
| 90 trading days | C$0.06 | C$0.03 – C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Keep an eye on Hemostemix's efforts to strengthen its market position, especially through recent corporate updates and partnerships.
Hemostemix Inc sees a 7.69% increase in stock price
The market cap of Hemostemix Inc is currently CA$14.35 million, reflecting its status as a small-cap player in the biotechnology sector.
Bull case
Hemostemix's recent stock rise is likely due to its proactive approach in securing funding and improving its operations. Completing a private placement could indicate growing investor confidence and a commitment to future growth.
Bear case
However, despite this positive movement, the company faces challenges. Its lack of substantial profit margins and ongoing dependence on private placements may raise concerns about its long-term sustainability and profitability.
Advertisement
Recent Corporate Developments
Hemostemix has been actively engaging with investors and enhancing its operational capabilities. The recent completion of a private placement of USD $336,500 at $0.295 per share shows the company's dedication to securing funding for ongoing projects. These initiatives could be crucial for driving future growth and boosting investor confidence.
Market Sentiment and Future Outlook
The positive movement in Hemostemix's stock today reflects a growing sentiment among investors. As the company ramps up its engagement with new investors and improves its operational framework, it may attract further interest. However, potential investors should remain cautious about the inherent risks associated with small-cap biotech firms.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
